Research Progress on Dexmedetomidine Regulating Autophagy in the Treatment of Acute Lung Injury
Cardiovascular Reviews · 2023
DOI: 10.26689/cr.v1i3.5746 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Reviews, 2023. Verfasst von Guanrong Li und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Dexmedetomidine, extensively utilized as an intravenous anesthetic in anesthesia, intensive care units, and other related medical departments, exhibits significant anti-inflammatory effects while inducing sedation. Numerous studies have demonstrated its capability to regulate autophagy, thereby exerting potent anti-inflammatory effects and offering therapeutic benefits in the treatment of acute lung injury. This article comprehensively reviews the mechanisms underlying autophagy, the role of dexmedetomidine in autophagy regulation, and the protective effects it conders in the context of acute lung injury. By doing so, it contributes positively to the arsenal of strategies aimed at both preventing and treating acute lung injury.
Zitieren
APA
Li, G., Li, M., Wang, Y., Ma, H., Zhang, B., Chen, J., & Sun, Y. (2023). Research Progress on Dexmedetomidine Regulating Autophagy in the Treatment of Acute Lung Injury. Cardiovascular Reviews. https://doi.org/10.26689/cr.v1i3.5746
Vancouver
Li G, Li M, Wang Y, Ma H, Zhang B, Chen J, et al. Research Progress on Dexmedetomidine Regulating Autophagy in the Treatment of Acute Lung Injury. Cardiovascular Reviews. 2023. doi:10.26689/cr.v1i3.5746
BibTeX
@article{Li2023,
author = {Li, Guanrong and Li, Min and Wang, Ying and Ma, Huijie and Zhang, Boya and Chen, Jun and Sun, Yingui},
title = {Research Progress on Dexmedetomidine Regulating Autophagy in the Treatment of Acute Lung Injury},
journal = {Cardiovascular Reviews},
year = {2023},
doi = {10.26689/cr.v1i3.5746}
}
EUVIMED